Sarah Johnson, PharmD, MBA is a Director of Medical Oncology Strategic Accounts at GlaxoSmithKline. In her role within Medical Affairs, she works with key cancer centers in the Midwest to develop strategic partnership opportunities across the entire GSK oncology portfolio. These collaborative partnerships include addressing cancer care disparities in underserved communities. with the goal of bringing industry leaders and cancer care providers together to focus on grass roots efforts to increase diversity in clinical trials. Sarah has over 20 years experience as a pharmacist responsible for drug policy, research, education, and clinical services followed by several years of experience within Medical Affairs in the pharmaceutical industry.